AzTrials
AzTrials

Thiamin DeficiencyPhase 1NCT02221063

Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia

A Phase 1 study testing Thiamin fortified fish sauce (low concentration) and Thiamin fortified fish sauce (higher concentration) in people with Thiamin Deficiency, run by University of British Columbia at 1 site in Cambodia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether consumption of thiamin fortified fish sauce over 6 months increases the thiamin status of women to a level consistent with a low risk of infantile beriberi. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Thiamin Deficiency
What is being tested?
Thiamin fortified fish sauce (low concentration) and Thiamin fortified fish sauce (higher concentration)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
366 participants
Where
1 siteCambodia
Study dates
Oct 2014to Apr 2016
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women of Childbearing Age Cohort:
  • be the female head of their household,
  • have at least one child between 12 - 59 months of age at baseline,
  • be living in Prey Veng province, Cambodia, and not planning to move in the next six months,
  • agree to exclusively feed her entire household the study fish sauce for six months, and
  • be willing to provide venous blood samples at baseline and endline.
Show all 14Show fewer
  • Pregnant Women Cohort:
  • be the female head of their household,
  • be ~3-8 mo pregnant with a singleton fetus at baseline,
  • have no prior history of preeclampsia, pre-term delivery, or birth defects,
  • know her approximate due date,
  • be living in Prey Veng province, Cambodia, and not planning to move in the next six months,
  • agree to exclusively feed her entire household the study fish sauce for six months, and
  • be willing to provide venous blood samples at baseline and endline, a breast milk sample at endline, and to allow for a blood sample to be taken from her infant (aged ~3 months) at endline.

Who cannot join

  • Women of Childbearing Age Cohort:
  • not be receiving any other intervention (for example, homestead food production),
  • not be pregnant or hoping to become pregnant within the next 6 months, and
  • not be taking any supplement that contains thiamin.
  • Pregnant Women Cohort:
  • not be receiving any other intervention (for example, homestead food production), and
  • not be taking any supplement that contains thiamin.

Trial locations and contacts

1 site in 1 country.

Cambodia1 site
  • Study site

    (Various Villages), Prey Veng

Other trials in Cambodia

About this study

The purpose of this study is to determine whether consumption of thiamin fortified fish sauce over 6 months increases the thiamin status of women to a level consistent with a low risk of infantile beriberi. The investigators hypothesize that consumption of thiamin-fortified fish sauce will increase red blood cell thiamin concentrations, an indicator of thiamin status, in women consuming thiamin-fortified fish sauce, while concentrations will not change in women consuming a placebo fish sauce that does not contain thiamin.

Read the detailed description

Purpose The purpose of this three-armed, double blind randomized control trial is to determine whether thiamin-fortified fish sauce is an efficacious means of increasing dietary thiamin intake in Cambodian women to a level that increases erythrocyte thiamin diphosphate (TDP) concentrations to a level consistent with a low risk of infantile beriberi. Two groups of women will participate in this study: women of childbearing age (18-45y; n=270), and pregnant women (18-45y; ~26 weeks pregnant at baseline; n=90).

Hypothesis Intervention with thiamin-fortified fish sauce will increase women's TDP concentrations to levels consistent with a low risk of infantile beriberi compared to those receiving the control fish sauce.

Study Justification Beriberi is a micronutrient deficiency disease caused by a lack of thiamin (vitamin B1) in the diet. Infantile beriberi is common in Southeast Asia.

Beriberi, a disease caused by severe thiamin deficiency, is rare in the west but is thought to be more common in developing countries, particularly those in Southeast Asia. In infants, beriberi presents with symptoms of heart failure and is fatal unless thiamin treatment is initiated immediately. Beriberi typically presents in exclusively breastfed infants whose mothers have suboptimal thiamin status and consequently have low breast milk thiamin concentrations. Maternal thiamin deficiency in Cambodia is likely a result of multiple factors: the high consumption of white, polished rice, which has been removed from its B-vitamin-containing husk, a lack of parboiling rice, and low dietary diversity. Improving the thiamin status of pregnant and lactating women is essential for combating infantile beriberi. Fortification of a food staple has proven to be a successful strategy in increasing population levels of thiamin because as a 'passive' intervention, it requires little to no behavior change. Fish sauce is an ideal vehicle for thiamin fortification: it is consumed daily in consistently high quantities, and is produced in centralized plants, and has been successfully used in Cambodia and Vietnam as a vehicle for iron fortification.

Research Method All villages in Prey Veng province that are not already involved in an active intervention (for example, homestead food production, micronutrient powder intervention etc) will be randomized. A Khmer-speaking research assistant will contact the Village Chief and/or Village Health Volunteer in the first village on the randomized list and determine the number of eligible women of childbearing age and pregnant women (~26 weeks) in that village. The research assistant will move down the randomized list of villages until 360 participants have been enrolled. The investigators expect enrolment from approximately 10 villages.

A trained, Khmer-speaking enumerator will conduct an interview in the participants home. The questionnaire will collect demographic data, as well as information on dietary intake (including fish sauce), thoughts and perceptions of fortified products, and knowledge of thiamin deficiency and beriberi. Once the questionnaire is complete the participant will walk with the interviewer to a central meeting spot within the village (typically the Village Chief's home) to complete anthropometric measurements (height and weight). The next morning the participant will travel to the local health centre for a non-fasted blood draw.

Once the participant completes the baseline questionnaire, anthropometrics, and blood collection she will be randomly assigned to one of the three treatment groups: low concentration thiamin-iron-fortified fish sauce (2mg thiamin/mL fish sauce + iron), higher concentration thiamin-fortified fish sauce (8mg thiamin/mL fish sauce + iron), or placebo: iron-fortified fish sauce. The bottles and labels of the three fish sauces will be identical in appearance, except for a code that differentiates the sauces.

All participants will be visited biweekly for monitoring and evaluation of fish sauce consumption. Fish sauce will be distributed during these visits to ensure that there are no 'stock outs' of fish sauce during the study.

Within the first month of the study all participants will attend an educational workshop with training regarding dietary thiamin intake, thiamin deficiency and beriberi, and infant and young child feeding (IYCF) practices.

Anthropometric measurements (weight and length) will be taken within 72 hours of the birth of the participant's infant (t~3 months).

At t~4 months, a subset of households (n=28) will participate in an Observed Weighed Fish Sauce Record wherein a trained enumerator measure all fish sauce consumed by the participant throughout one day. Two repeat observed weighed fish sauce records will be completed within a 2 week period.

At endline (t=6 months), the questionnaire, anthropometrics, and blood draw will be repeated with all women. The investigators will also collect a venous blood sample (4mL) from the infant, and a breast milk sample from mothers from the pregnant cohort. Investigators plan to analyze all samples within two months of the endline sample collection, and will return to the villages to share study findings with all participants at a community meeting (general results shared), and then separately to share individual thiamin results one-on-one. All participants will have already participated in an educational workshop highlighting the importance of dietary thiamin intake, and the signs of thiamin deficiency and beriberi. Individuals with suboptimal thiamin status will be encouraged to speak with their healthcare provider, and will also be counselled using the materials that were previously used in the educational workshop.

Being tested
Thiamin fortified fish sauce (low concentration), Thiamin fortified fish sauce (higher concentration), Placebo fish sauce
Keywords
thiamin, thiamin diphosphate, beriberi, Cambodia, fish sauce, fortification, pregnancy, breastfeeding, childbearing age
Medical subject headings
Beriberi, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thiamin fortified fish sauce (low concentration)Other

    Low concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

  • Thiamin fortified fish sauce (higher concentration)Other

    Higher concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

  • Placebo fish sauceOther

    Fish sauce fortified only with iron, not thiamin, will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

Study groups in NCT02221063
Study groupRoleWhat they receive
low [thiamin] fortified fish sauceActive comparatorFish sauce will contain 2 mg thiamin hydrochloride / mL fish sauce + iron (as NaFeEDTA)
Receives: Other: Thiamin fortified fish sauce (low concentration)
higher [thiamin] fortified fish sauceActive comparatorFish sauce will contain 8 mg thiamin hydrochloride / mL fish sauce + iron (as NaFeEDTA)
Receives: Other: Thiamin fortified fish sauce (higher concentration)
Placebo fish saucePlacebo comparatorFish sauce will contain only iron (as NaFeEDTA), no thiamin
Receives: Other: Placebo fish sauce

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Erythrocyte thiamin diphosphate

    Measurement at baseline and endline for all women. Blood samples from infants of women recruited in the pregnancy cohort will be collected at endline only.

    Measured: Baseline (t=0), Endline (t=6 months)

Secondary outcomes (1)
  1. Breast milk thiamin concentration

    Breast milk will collected only from those women recruited in the pregnancy cohort (n=90)

    Measured: Endline (t=6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionApr 2015
  4. Study completionApr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
366 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02221063
Sponsor's protocol ID
H14-00103
Other IDs
S6 0490-01-10
Status last verified
May 2016
First submitted
18 Aug 2014
Last updated
25 May 2016
Results posted
No
Data monitoring committee
No

Publications

  • Whitfield KC, Karakochuk CD, Kroeun H, Sokhoing L, Chan BB, Borath M, Sophonneary P, Moore K, Tong JKT, McLean J, Talukder A, Lynd LD, Li-Chan ECY, Kitts DD, Green TJ. Household Consumption of Thiamin-Fortified Fish Sauce Increases Erythrocyte Thiamin Concentrations among Rural Cambodian Women and Their Children Younger Than 5 Years of Age: A Randomized Controlled Efficacy Trial. J Pediatr. 2017 Feb;181:242-247.e2. doi: 10.1016/j.jpeds.2016.10.066. Epub 2016 Dec 7.

    PubMed 27939124
  • Whitfield KC, Karakochuk CD, Kroeun H, Hampel D, Sokhoing L, Chan BB, Borath M, Sophonneary P, McLean J, Talukder A, Lynd LD, Li-Chan EC, Kitts DD, Allen LH, Green TJ. Perinatal Consumption of Thiamine-Fortified Fish Sauce in Rural Cambodia: A Randomized Clinical Trial. JAMA Pediatr. 2016 Oct 3;170(10):e162065. doi: 10.1001/jamapediatrics.2016.2065. Epub 2016 Oct 3.

    PubMed 27532780

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Thiamin fortified fish sauce (low concentration) and Thiamin fortified fish sauce (higher concentration) in people with Thiamin Deficiency, run by University of British Columbia at 1 site in Cambodia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cambodia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Erythrocyte thiamin diphosphate (time frame: Baseline (t=0), Endline (t=6 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02221063, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in